🏛️ Verified NIH Record • Updated 2025-11-06
Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors (NCT03803423)
🟢 Recruiting Observational / Diagnostic 📋 Clinical Research Protocol Sponsor: Johns Hopkins University
🩺 Plain-English Summary (8th-Grade Level)
This study utilizes a web-based application to help patients on the organ transplant waitlist communicate patient's need for a living donor via social media and provide interested potential donors the opportunity to engage with the evaluation process.
Who can join: Review the eligibility criteria below.
Location: Scripps Green Hospital — San Diego, California
Age range: 18 Years
🧪 Interventions in This Study
- The Donor App (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (6 Sites)
- Scripps Green Hospital — San Diego, California
- Yale University — New Haven, Connecticut
- Rush University Medical Center — Chicago, Illinois
- Maine Medical Center — Portland, Maine
- The Johns Hopkins Hospital — Baltimore, Maryland
- Washington University in St. Louis — St Louis, Missouri
📞 Contact the Study Coordinator
Phone: (443) 287-0134
Email: donorapp@jhu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in End Stage Renal Disease
- Light Therapy in End Stage Kidney Disease — Philadelphia, Pennsylvania
- Ferric Citrate in ESRD Pilot Project — Houston, Texas
- Central Blood Pressure and Pulse Wave Velocity in Kidney Transplant Recipients — Washington D.C., District of Columbia
- Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease — New York, New York
- Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis — San Antonio, Texas
- PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis — Washington D.C., District of Columbia
Explore by condition: All End Stage Renal Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.